Intracarotid tumor necrosis factor-α administration increases the blood-brain barrier permeability in cerebral cortex of the newborn pig: Quantitative aspects of double-labelling studies and confocal laser scanning analysis

Neuroscience Letters

Volumn 208, Issue 2, 1996, Pages 85-88

  Ábrahám, Csongor S ^a   Deli, Mária A ^b   Joó, Ferenc ^b   Megyeri, Pál ^a   Torpier, Gérard ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF BIOCHEMISTRY   (Hungary)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Blood brain barrier; Brain edema; Tumor necrosis factor

Indexed keywords

FLUORESCENT DYE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SWINE;

ALBUMINS; ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; CAROTID ARTERIES; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; EVANS BLUE; FEMALE; FLUORESCEIN; FLUORESCEINS; INJECTIONS, INTRA-ARTERIAL; LASERS; MALE; MICROSCOPY, CONFOCAL; SWINE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029922884     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3940(96)12546-5     Document Type: Article

References (30)

1. Ábrahám, C.S., Deli, M.A., Joó, F., Megyeri, P. and Torpier, G., Intracarotid tumor necrosis factor α administration results in vasogenic brain edema formation in newborn pigs (abstr.), Pediatr. Res., 37 (1995) 287A.
2. Ábrahám, C.S., Kovács, J. and Temesvári, P., Permanent vasodilatation, transient arteriolar vasospasm and progressive venous stasis in pial-arachnoid microvessels of newborn piglets during bilateral pneumothorax, Pediatr. Rev. Commun., 6 (1991) 1-12.
3. Beutler, B. and Grau, G.E., Tumor necrosis factor in the pathogenesis of infectious diseases, Crit. Care Med., 21 (1993) S423-S435.
4. de Bont, E.S., Martens, A., van Raan, J., Samson, G., Fetter, W.P., Okken, A., de Leij, L.H. and Kimpen, J.L., Diagnostic value of plasma levels of tumor necrosis factor alpha (TNFα) and interleukin 6 (1L-6) in newborns with sepsis, Acta Paediatr., 83 (1994) 696-699.
5. Deli, M.A., Descamps, L., Dehouck, M.-P., Cecchelli, R., Joó, F., Ábrahám, C.S. and Torpier, G., Exposure of tumor necrosis factor-α to the luminal membrane of bovine brain capillary endothelial cells cocultured with astrocytes induces a delayed increase of permeability and cytoplasmic stress fiber formation of actin, J. Neurosci. Res., 41 (1995) 717-726.
6. Feuerstein, G.Z., Liu, T. and Barone, F.C., Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha, Cerebrovasc. Brain Metab. Rev., 6 (1994) 341-360.
7. Fillit, H., Ding, W., Buee, L., Kalman, J., Altstiel, L., Lawlor, B. and Wolf-Klein, G., Elevated circulating tumor necrosis factor levels in Alzheimer's disease, Neurosci. Lett., 129 (1991) 318-320.
8. Goldblum, S.E., Ding, X. and Campbell-Washington, J., TNF-α induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction, Am. J. Physiol., 264 (1993) C894-C905.
9. Grau, G.E., Taylor, T.E., Molyneux, M.E., Wirima, J.J., Vassalli, P., Hommel, M. and Lambert, P.-H., Tumor necrosis factor and disease severity in children with Falciparum malaria, N. Engl. J. Med., 320 (1989) 1586-1591.
10. Grimaldi, L.M.E., Martino, G.V., Franciotta, D.M., Brustia, R., Castagna, A., Pristera, R. and Lazzarin, A., Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement, Ann. Neurol., 29 (1991) 21-25.
11. Gutierrez, E.G., Banks, W.A. and Kastin, A.J., Murine tumor necrosis factor alpha is transported from blood to brain in the mouse, J. Neuroimmunol., 47 (1993) 169-176.
12. Hassel, B., Iversen, E.G. and Fonnum, F., Neurotoxicity of albumin in vivo, Neurosci. Lett., 167 (1994) 29-32.
13. Hofman, F.M., Hinton, D.R., Johnson, K. and Merrill, J.E., Tumor necrosis factor identified in multiple sclerosis brain, J. Exp. Med., 170 (1989) 607-612.
14. Kim, K.S., Wass, C.A., Cross, A.S. and Opal, S.M., Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat, Lymphokine Cytokine Res., 11 (1992) 293-298.
15. Lähdevirta, J., Maury, C.P.J., Teppo, A.-M. and Repo, H., Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome, Am. J. Med., 85 (1988) 289-291.
16. Leist, T.P., Frei, K., Kam-Hansen, S., Zinkernagel, R.M. and Fontana, A., Tumor necrosis factor α in cerebrospinal fluid during bacterial, but not viral, meningitis: evaluation in murine model infections and in patients, J. Exp. Med., 167 (1988) 1743-1748.
17. Levine, B., Kalman, J., Mayer, L., Gillit, H.M. and Packer, M., Elevated circulating levels of tumor necrosis factor in severe chronic heart failure, N. Engl. J. Med., 323 (1990) 236-241.
18. Maury, C.P.J. and Teppo, A.-M., Raised serum levels of cachectin/tumor necrosis factor α in renal allograft rejection, J. Exp. Med., 166 (1987) 1132-1137.
19. McGuinness, M.C., Griffin, D.E., Raymond, G.V., Washington, C.A., Moser, H.W. and Smith, K.D., Tumor necrosis factor-α and X-linked adrenoleukodistrophy, J. Neuroimmunol., 61 (1995) 161-169.
20. Megyeri, P., Ábrahám, C.S., Temesvari, P., Kovács, J. and Speer, C.P., Tumor-Nekrose-Faktor α induziert die Öffnung der Blut-Hirn-Schranke: Eine tierexperimentelle Untersuchung. In F. Hanefeld, D. Rating and H.-J. Christen (Eds.), Actuelle Neuropädiatrie 1989, Springer-Verlag, Berlin, 1990, pp. 245-248.
21. Megyeri, P., Ábrahám, C.S., Temesvári, P., Kovács, J., Vas, T. and Speer, C.P., Recombinant human tumor necrosis factor α constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets, Neurosci. Lett., 148 (1992) 137-140.
22. Mintz, M., Rapaport, R., Oleske, J.M., Connor, E.M., Koenigsberger, R., Denny, T. and Epstein, L.G., Elevated serum levels of tumor necrosis factor are associated with progressive encephalopathy in children with acquired immunodeficiency syndrome. Am. J. Dis. Child., 143 (1989) 771-774.
23. Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K. and Nagatsu, T., Tumor necrosis factor-α increases both in the brain and in the cerebrospinal fluid from parkinsonian patients, Neurosci. Lett., 165 (1994) 208-210.
24. Murata, J., Betz Corradin, S., Janzer, R.C. and Juillerat-Jeanneret, L., Tumor cells suppress cytokine-induced nitric oxide (NO) production in cerebral endothelial cells. Int. J. Cancer, 59 (1994) 699-705.
25. Saija, A., Princi, P., Lanza, M.. Scalese, M., Aramnejad, E. and De Sarro, A., Systemic cytokine administration can affect blood-brain barrier permeability in the rat. Life Sci., 56 (1995) 775-784.
26. Scuideri, P., Sterling, K.E., Lam, K.S, Finley, P.R., Ryan, K.J., Ray, C.G., Petersen, E., Slymen, D.J. and Salmon, S.E., Raised serum levels of tumor necrosis factor in parasitic infections, Lancet, ii (1986) 1364-1365.
27. Sharief, M.K. and Thompson, E.J., In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis, J. Neuroimmunol., 38 (1992) 27-32.
28. Tureen, J., Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide, J. Clin. Invest., 95 (1995) 1086-1091.
29. Waage, A., Halstensen, A. and Espevik, T., Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet, i (1987) 355-357.
30. Wright, J.L. and Merchant R.E., Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-α in the rat, J. Neurooncol., 20 (1994) 17-25.